logo
15:53 Jun 12

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2293.30
+20.00 (+0.88%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lupin Ltd. Financials

Lupin Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2293.30
+20.00 (+0.88%)
15:53 Jun 12
Quality
image/svg+xml

79/100
High Financial Strength

Valuation
image/svg+xml

48/100
Mid Valuation

Technical

56/100
Technically Neutral

Strength

16

Weakness

3

Opportunity

1

Threats

1

23.75 %

ROE %

13.90 %

ROA %

116.63

EPS

490.99

BVPS

19.07 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
16405.48 16641.66 20010.82 22707.9 27958.03
Operating Expenses +
16118.26 14843.54 16200.3 17424.59 19142.03
Raw Material
6679.56 6626.03 7100.91 7100.03 7488.91
Increase Decrease in Cost
-198.32 153.73 -457.44 -257.78 -162.45
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2989.3 3087.15 3494.57 3964.2 4574.53
Miscellaneous Expenses
13535.42 10853.07 11979.7 11903.38 12975.06
Operating Profit
287.22 1798.12 3810.52 5283.31 8816
Other Income
141.69 73.36 120.17 195.82 424.45
Depreciation
1658.71 880.69 1196.81 1169.26 1375.5
Interest
142.77 274.3 311.61 294.87 434.49
Profit before tax and exceptio..
-1372.57 716.49 2422.27 4015 7430.46
Exceptional Items
0 0 0 0 -557.91
PBT
-1372.57 716.49 2422.27 4015 6872.55
Provision for Taxation
137.15 268.8 486.7 708.74 1517.08
Net Profit
-1509.72 447.69 1935.57 3306.26 5355.47
NET Profit after MI
-1528.04 430.08 1914.48 3281.62 5332.84
EPS
-33.65 9.41 41.87 71.95 116.44
Operating Profit Margin (%)
1.75 10.8 19.04 23.27 31.53
Net Profit Margin (%)
-9.31 2.58 9.57 14.45 19.07

Lupin Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: